| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.03 |